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In this paper, we propose a novel method that combines PubMed knowledge and Electronic Health
Records to develop a weighted Bayesian Network Inference (BNI) model for pancreatic cancer prediction.
We selected 20 common risk factors associated with pancreatic cancer and used PubMed knowledge to
weigh the risk factors. A keyword-based algorithm was developed to extract and classify PubMed
abstracts into three categories that represented positive, negative, or neutral associations between each
risk factor and pancreatic cancer. Then we designed a weighted BNI model by adding the normalized
weights into a conventional BNI model. We used this model to extract the EHR values for patients with
or without pancreatic cancer, which then enabled us to calculate the prior probabilities for the 20 risk
factors in the BNI. The software iDiagnosis was designed to use this weighted BNI model for predicting
pancreatic cancer. In an evaluation using a case-control dataset, the weighted BNI model signiﬁcantly
outperformed the conventional BNI and two other classiﬁers (k-Nearest Neighbor and Support Vector
Machine). We conclude that the weighted BNI using PubMed knowledge and EHR data shows remarkable
accuracy improvement over existing representative methods for pancreatic cancer prediction.
 2011 Elsevier Inc. All rights reserved.1. Introduction predictions in the BNI model, while other classiﬁers often requireEvery year, many people die of ‘‘silent killers’’, those fatal dis-
eases that are hard to diagnose and treat. Pancreatic cancer is one
such disease. Early diagnosis is crucial to its successful treatment.
In addition to searching for effective biomarkers [1,2] which can
aid in early diagnosis, researchers have developed models to sup-
port disease risk prediction [3,4]. The Bayesian Network Inference
(BNI) model, which uses Bayes’ theorem and represents probabilis-
tic dependencies between disease-associated risk factors as a direc-
ted acyclic graph [5,6], has been a popular disease risk prediction
model [7,8], especially for predicting breast cancer [9–17] and pan-
creatic cancer [18]. Several factors make the BNI model a better
choice than othermethods for disease risk prediction. First, whereas
other classiﬁcation methods, such as the k-Nearest Neighbor (KNN)
and Support Vector Machine (SVM) methods, excel primarily in a
high-dimensional feature space, the BNI model performs well in a
low-dimensional feature space. Second, the BNI model can repre-
sent the joint probability distribution over interrelated hypotheses
about disease risk factors using network topology, but other classi-
ﬁcation models cannot represent or use this valuable information.
Third, heterogeneous or randomvariables can be combined tomakell rights reserved.
dical Informatics, Columbia
32, United States. Fax: +1 212variables of the same type. A recent advance in BNI modeling is
weighted model counting, which uses a propositional knowledge
base for improving prediction accuracy [19], although this method
has rarely been used in clinical decision support.
In this paper, we propose a novel extension to the conventional
BNI by combining text mining of PubMed knowledge with second-
ary use of clinical data from Electronic Health Records (EHR) to de-
velop a weighted BNI model. We used PubMed, because as a rich
public knowledge base, it contains ofﬁcial evidence of the associa-
tions between risk factors and diseases. We developed a text min-
ing-based method which allows us to statistically weigh each of
these associations. We make use of EHR clinical date because, with
the expanding adoption of EHR worldwide, the rich clinical data
they provide serves as additional practical evidence for disease
modeling. We hypothesize that by combining PubMed and EHR,
we can calculate the prior probabilities of a weighted BNI model
for disease risk prediction.
Next we present the design of such a weighted BNI model and
its evaluation results. Note that while we used pancreatic cancer
as a sample disease in our initial study, the method should gener-
alize to other diseases.
2. Data sources and methods
Fig. 1 shows our process for developing a weighted BNI model
for pancreatic cancer prediction. It consists of seven steps: (1)
Fig. 1. Steps to construct a node-weighted BNI.
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ﬁcation; (3) variable weight computation; (4) weighted Bayesian
Network topology design; (5) EHR data extraction for prior proba-
bility calculation; (6) iDiagnosis Graphic User Interface (GUI) de-
sign; and (7) model evaluation.
2.1. Variable selection
We identiﬁed 31 variables associated with pancreatic cancer by
aggregating the results from a PubMed review, the recommenda-
tions by clinical experts on pancreatic cancer in our institution,
and the risk factors associated with pancreatic cancer we had pre-
viously identiﬁed [20,21]. Fig. 2 shows the class hierarchy of the
risk factors, which fall into ﬁve categories: demographics, life style,
symptoms, co-morbidities, and lab test results.
Since knowledge representation always involves making trade-
offs between tractability and expressiveness [22], the more vari-
ables used, the more complex the BNI model inference process.
To curb complexity and improve efﬁciency for the BNI model, we
considered two issues when selecting and aggregating a subset of
these variables to construct the weighted BNI model: (1) the avail-
ability and quality of the information in EHR; for example, infor-
mation about food intake is generally inaccessible or incomplete
in EHR and hence is excluded; and (2) the importance of a variable
according to the frequency of it being discussed in PubMed and the
recommendation of clinical experts. In addition, to simplify the BNI
model design, similar variables were manually grouped into one.
For example, variable ‘‘alcohol abuse’’ and ‘‘cigarette abuse’’ were
grouped into one variable ‘‘alcohol or cigarette abuse’’ since they
were both ‘‘substance abuse’’. Similarly, the variables ‘‘fatigue’’
and ‘‘asthenia’’ were grouped into one variable ‘‘fatigue or asthe-
nia’’ since they are semantically similar or related symptoms.
Based on the above considerations, we identiﬁed the following
20 variables to design our BNI models: age, alcohol or cigarette
abuse, abdominal pain, fatigue or asthenia, nausea, vomiting,
weight loss, depression, appetite loss, diabetes mellitus, jaundice,
carbohydrate antigen 19-9 (CA 19-9), carcinoembryonic antigen
(CEA), gamma-glutamyl transferase (GGT), glucose, alanine amino-
transferase (ALT), aspartate aminotransferase (AST), alkaline phos-
phatase (ALP), albumin and bilirubin. All these variables are
available in EHR, although half of them are in narrative format in
free-text notes.
2.2. PubMed knowledge extraction and processing
Many text-mining algorithms have already been developed to
extract disease-related risk factors from PubMed. Learning from apopular rule-based method designed by Chen et al. to calculate
associations among biological terms [23], we implemented a
keyword-based method to automatically extract and classify
PubMed abstracts that mentioned both any of the risk factors
and pancreatic cancer together to calculate the weight of each risk
factor. We implemented the program Entrez Programming Utilities
(eUtils) [8], which provides direct access to the PubMed databases
and supports terminology-based query term generation, informa-
tion extraction and exportation from PubMed abstracts. Medical
Subject Headings (MeSH) terms were used to generate query terms
for each variable. When searching for information in PubMed, we
used the eUtils ESearch tools. For each search, one MeSH term that
represents a variable and one MeSH term representing pancreatic
cancer were paired to issue a PubMed query searching for abstracts
discussing this variable and pancreatic cancer together in the title.
If the number of the retrieved abstracts was <100, the query was
expanded to search for the co-occurrence of the variable and pan-
creatic cancer in both the title and the abstract. If the number of
retrieved citations was still <100, the query was further expanded
to search the full text. The classiﬁcation accuracy of the included
PubMed abstracts decreased as the search scope was expanded
from the title to the full text since generally the co-occurrence of
a variable and pancreatic cancer in the title indicates a stronger
association than in the abstract. We used the eUtils Fetch tools to
download all abstracts into a local MySQL database.
2.3. Weight calculation
Each PubMed abstract was classiﬁed into one of the following
three categories according to the association between the selected
variable and pancreatic cancer: positive, negative, or neutral associ-
ation. Each variable was assigned a set of keywords indicating the
associations; details are shown in Appendix A Table A1. Keywords
indicating a positive association typically include ‘‘risk’’, ‘‘link’’,
‘‘associated’’, ‘‘association’’, ‘‘inﬂuence’’ and hundreds of others. Key-
words indicating a negative association typically includes ‘‘differen-
tiation’’, ‘‘comparison’’, ‘‘discrimination’’, ‘‘distinction’’, ‘‘distinguish’’
and about a hundred more. Keywords such as ‘‘equal to’’, ‘‘same to’’
and ‘‘sequential’’ were considered indicators of a neutral association.
Abstracts that included co-occurring variables and pancreatic can-
cer without obvious associations were categorized as neutral asso-
ciations. For example, a PubMed abstract may discuss biological
molecules such as insulin receptor substrate-1 protein or insulin-
like growth factor instead of the association between insulin and
pancreatic cancer. To ensure high accuracy in the abstract classiﬁca-
tion phase, themachine classiﬁcation results were further reviewed
manually and corrected as appropriate, although themanual review
was greatly enhanced by the text-mining algorithm since the sen-
tences containing the keywords were automatically highlighted to
ease the manual review.
For each risk factor, only the abstracts containing positive and
negative associations between the risk factor and pancreatic cancer
were used to calculate the original weights for each risk factor (woi ).
For variable Vi, Pi indicates the number of abstracts with positive
associations, Ni denotes the number of abstracts with negative
associations, and the original weight woi is the ratio between Pi
and Ni, calculated as:
w0i ¼
Pi
Ni
: ð1:1Þ
To avoid inﬁnity, if Ni equals 0, woi is assigned the value 1. The
rationale behind this design is that PubMed publications reﬂect
collective evidence regarding the association generated by subject
matter experts from all over the world and over time, who may dis-
agree with one another; therefore, the ratio between Pi and Ni is a
statistical summary of the collective evidence for the association
Fig. 2. Class hierarchy of pancreatic cancer variables.
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is calculated, a procedure of normalization, wi, is deﬁned as:
wi ¼ w
o
i
maxðwo1;wo2;   wo20Þ
; ð1:2Þ
where woi is the original weight deﬁned in Eq. (1.1), max(w
o
1,
wo2, . . . , w
o
20) is the maximum of the original weights w
o
i , and wi is
the normalized weight in the range [0, 1].
2.4. Node-weighted Bayesian Network Inference (BNI) model
development
Fig. 3 shows the topology of our weighted BNI model, which
separates dependent variables (e.g., co-morbidities, symptoms,
and lab test results that might be caused by pancreatic cancer)
from independent variables (e.g., age, gender, smoking and alcohol
abuse). Each risk factor is treated as a binary variable without con-
sidering the severity, degree, accumulative length, or other quanti-
tative information of the risk factor. The value ‘‘true’’ represents
the presence of a factor and the value ‘‘false’’ represents the
absence of a risk factor. To integrate the normalized weights into
the BNI model, we multiply the normalized weight, wi, of eachvariable to its corresponding prior probability P, as illustrated by
the simple network in Fig. 4a, where one node is pancreatic cancer
and the other node is variable Vi. The function of the weighted prior
probability is deﬁned as:
PwðVi ¼ truejpancreatic cancer ¼ trueÞ
¼ wi  PðVi ¼ truejpancreatic cancer ¼ trueÞ; ð2Þ
wherewi is the normalized weights in Eq. (1.2) with the range [0, 1].
Since the probability P(pancreatic cancer = true|Vi = true) is in the
range [0, 1], the normalized weights are bounded in [0, 1], and the
weighted prior probability Pw(Vi = true|pancreatic cancer = true) is in
the range [0, 1]. The weighted posterior probability Pw(pancreatic
cancer = true|Vi = true) can be calculated using the weighted prior
probability Pw(Vi = true|pancreatic cancer = true) deﬁned in Eq. (2).
Theorem One. The weighted posterior probability Pw(pancreatic
cancer = true|Vi = true) is a probability function.Proof. PC is the abbreviation for Pancreatic Cancer hereafter.
Given Bayes’ theorem and Eq. (2), the weighted posterior probabil-
ity Pw(PC = true|Vi = true) can be calculated as:
Fig. 3. The topology of the Bayesian Network for predicting pancreatic cancer.
PwðPC ¼ truejVi ¼ trueÞ ¼ PwðVi ¼ truejPC ¼ trueÞPðPC ¼ trueÞPwðVi ¼ truejPC ¼ trueÞPðPC ¼ trueÞ þ PðVi ¼ truejPC ¼ falseÞPðPC ¼ falseÞ : ð3Þ
Given Bayes’ theorem, the posterior probability P(PC=false | Vi=true) is:
PðPC ¼ falsejVi ¼ trueÞ ¼ PðVi ¼ falsejPC ¼ trueÞPðPC ¼ falseÞPðVi ¼ falsejPC ¼ trueÞPðPC ¼ trueÞ þ PðVi ¼ falsejPC ¼ falseÞPðPC ¼ falseÞ : ð4Þ
Summarizing Eq. (3) and Eq. (4), we arrive at
PwðPC ¼ truejVi ¼ trueÞ þ PðPC ¼ falsejVi ¼ trueÞ
¼ wi  PðVi ¼ truejPC ¼ trueÞPðPC ¼ trueÞ
wi  PðVi ¼ truejPC ¼ trueÞPðPC ¼ trueÞ þ PðVi ¼ truejPC ¼ falseÞPðPC ¼ falseÞ
þ PðVi ¼ falsejPC ¼ trueÞPðPC ¼ falseÞ
PðVi ¼ falsejPC ¼ trueÞPðPC ¼ trueÞ þ PðVi ¼ falsejPC ¼ falseÞPðPC ¼ falseÞ :
¼ 1:
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ability function. h
Eq. (3) shows that for each variable Vi, the value of the posterior
probability Pw(pancreatic cancer = true|Vi = true) depends on both
the prior probability P(pancreatic cancer = true|Vi = true) and the
normalized weight wi. If the variable and pancreatic cancer areFig. 4. A simpliﬁed Bayesian Network for pancreatic cancer prediction: (a) two-
node Bayesian Network (b) three-node Bayesian Network, where Vup is the set of all
parent nodes of PC and Vdown is the set of all child nodes of pancreatic cancer.positively associated, the normalized weight wi  1, and the
weighted posterior probability Pw(pancreatic cancer = true|Vi = true)
is approximately equal to the conventional posterior probability
P(pancreatic cancer = true|Vi = true). This means that the posterior
probability of pancreatic cancer increases if variable Vi is true. If
the variable and pancreatic cancer are negatively associated, the
normalized weight wi  0, and the posterior probability Pw(pancre-
atic cancer = true|Vi = true) is approximately equal to 0, which
means that the posterior probability of pancreatic cancer barely
increases.
Next we illustrate how wi can increase the BNI prediction accu-
racy for pancreatic cancer using a two-node Bayesian Network in
Fig. 4a. For example, if we use ‘‘vomiting’’ or ‘‘abdominal pain’’ to
instantiate Vi to predict the risk of pancreatic cancer, according to
the prior probabilities in Table 2, P( vomiting = true|pancreatic
cancer = true) = 0.4592 and P(abdominal pain = true|pancreatic
cancer = true) = 0.3980, respectively. To instantiate the model for
illustration purposes only, we suppose the prior probability of
pancreatic cancer is P(PC = true) = 103. According to the Bayes’
Theorem, using the two-node network in Fig. 4a, we would arrive
Table 2
Calculated prior probabilities with the condition pancreatic cancer = true (data source: EHR, the 98-case dataset).
Variable Probability Percent Ranking
Glucose P(glucose = true|PC = true) 0.8776 1
Albumin P(albumin = true|PC = true) 0.6536 2
Nausea P(nausea = true|PC = true) 0.5102 3
AgeP 60 P(ageP 60|PC = true) 0.4592 4
Vomiting P(vomiting = true|PC = true) 0.4592 4
Abdominal pain P(abdominal pain = true|PC = true) 0.3980 6
Weight loss P(weight loss = true|PC = true) 0.3776 7
Diabetes P(diabetes = true|PC = true) 0.3367 8
Smoking/drinking (UNION) P(smoking or alcohol = true|PC = true) 0.3163 9
Appetite loss P(appetite loss = true|PC = true) 0.2347 10
ALT P(ALT = true|PC = true) 0.1633 11
Fatigue/asthenia P(fatigue or asthenia = true|PC = true) 0.1531 12
CEA P(CEA = true|PC = true) 0.1429 13
Depression P(depression = true|PC = true) 0.1327 14
GGT P(GGT = true|PC = true) 0.1327 14
CA 19-9 P(CA 19-9 = true|PC = true) 0.1122 16
AST P(AST = true|PC = true) 0.1122 16
Bilirubin P(bilirubin = true|PC = true) 0.0918 18
ALP P(ALP = true|PC = true) 0.0816 19
Jaundice P(jaundice = true|PC = true) 0.0204 20
Table 1
Calculated weights and rankings for the 20 risk factors (data source: PubMed).
Variable Positive Negative Original weight Normalized weight Ranking
Weight loss 58 0 58 1 1
Glucose 51 0 51 0.8793 2
CA 19-9 48 0 48 0.8276 3
Diabetes 74 2 37 0.6379 4
Albumin 33 0 33 0.5690 5
Appetite loss 32 0 32 0.5517 6
CEA 59 2 29.5 0.5086 7
Bilirubin 29 0 29 0.5000 8
Abdominal pain 28 0 28 0.4828 9
Depression 52 2 26 0.4483 10
Jaundice 12 3 4 0.0690 11
Nausea 2 0 2 0.0345 12
Fatigue/asthenia 1 0 1 0.0172 13
Vomiting 1 0 1 0.0172 14
GGT 0 0 0 0 15
ALP 0 0 0 0 15
AST 0 0 0 0 15
ALT 0 0 0 0 15
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atic cancer = true|vomiting = true) = 8.4924  104 and P(pancreatic
cancer = true|abdominal pain = true) = 6.6135  104. However,
looking at the calculated prior probabilities, one may infer that
‘‘vomiting’’ is associated with pancreatic cancer to the same degree
as ‘‘abdominal pain’’. However, the pure probability information is
inconsistent with the existing medical knowledge that abdominal
pain is more strongly associated with pancreatic cancer than vom-
iting. By using the normalized weights for pancreatic cancer risk
factors in Table 1: wabdominal pain = 0.4828 or wvomiting = 0.0172 and
applying formula Eq. (2) and Eq. (3) to the two-node network in
Fig. 4a, we obtain theweighted posterior probabilities Pw(pancreatic
cancer = true|abdominal pain = true) = 6.6135  104 and Pw(pancre-
atic cancer = true|vomiting = true) = 1.4619  105. The former is
signiﬁcantly higher than the latter, which is consistent with our
medical knowledge. Therefore, the weighted posterior probabilities
are more realistic and consistent with prior knowledge about the
risk factors and can correct possible errors introduced by pure
statistics.
Fig. 4b explains why the normalized weightswi can increase the
BNI prediction accuracy for pancreatic cancer using a three-node
Bayesian Network with the variable set V = (Vdown
S
Vup), where
nodes Vup are the set of parent nodes of the decision node (‘‘the risk
of pancreatic cancer’’) and nodes Vdown are the set of all childrennodes of the decision node. After the prior probabilities are
weighted, based on Theorem 3.1 in [24], we obtain:
PðPC ¼ truejV ¼ trueÞ ¼ PðPC ¼ truejVup ¼ true;Vdown ¼ trueÞ
¼ PðVup ¼ true;Vdown ¼ truejPC ¼ trueÞPðVup ¼ trueÞ
PðVup ¼ true;Vdown ¼ trueÞ
¼ PðVup ¼ trueÞPðPC ¼ trueÞ
PðPC ¼ trueÞPðVup ¼ true;Vdown ¼ trueÞ ; PwðVdown
¼ truejPC ¼ trueÞPðPC ¼ truejVup ¼ trueÞ; ð5Þ
where V = (Vdown
S
Vup). We calculate the posterior probability
P(pancreatic cancer = true|Vup = true) using the method described in
[24], and Pw(Vdown = true|pancreatic cancer = true) is calculated as
follows:
PwðVdown ¼ truejPC ¼ trueÞ ¼ PwðVL ¼ truejPC ¼ trueÞPwðVR
¼ truejPC ¼ trueÞ ¼
X
l2L
PwðVl ¼ truejPC
¼ trueÞ
X
r2R
PwðVr ¼ truejPC ¼ trueÞ; ð6Þ
where Vdown = (VL
S
VR). Substituting Eq. (6) into Eq. (5), we can see
that the normalized weight wi contributes to the posterior probabil-
ity P(pancreatic cancer = true|V = true).
Table 3
Calculated prior probabilities with the condition pancreatic cancer = false (data source: EHR, the 14,971-control dataset).
Variable Probability Percent Ranking
Age P(ageP 60|PC = false) 0.4751 1
Diabetes P(diabetes = true|PC = false) 0.2458 2
Depression P(depression = true|PC = false) 0.2351 3
AST P(AST = true|PC = false) 0.2100 4
Albumin P(albumins = true|PC = false) 0.2000 5
ALP P(ALP = true|PC = false) 0.1900 6
Vomiting P(vomiting = true|PC = false) 0.1029 7
Nausea P(nausea = true|PC = false) 0.0855 8
Fatigue/asthenia P(fatigue or asthenia = true|PC = false) 0.0836 9
Smoking/drinking (UNION) P(smoking or alcohol = true|PC = false) 0.0626 10
Weight loss P(weight loss = true|PC = false) 0.0429 11
CEA P(CEA = true|PC = false) 0.0300 12
ALT P(ALT = true|PC = false) 0.0200 13
Appetite loss P(appetite = true|PC = false) 0.0129 14
Jaundice P(jaundice = true|PC = false) 0.0102 15
CA 19-9 P(CA 19-9 = true|PC = false) 0.0100 16
Abdominal pain P(abdominal pain = true|PC = false) 0.0013 17
GGT P(GGT = true|PC = false) 0 18
Glucose P(glucose = true|PC = false) 0 18
Bilirubin P(bilirubin = true|PC = false) 0 18
864 D. Zhao, C. Weng / Journal of Biomedical Informatics 44 (2011) 859–8682.5. EHR information extraction for prior probability calculation
For a BNI model, the prior probability of each variable is often
stored in a conditional probability table (CPT). We built such a
CPT using de-identiﬁed EHR information for pancreatic cancer pa-
tients which had been extracted from our institutional research
data warehouse. Two datasets were used to calculate the prior
probabilities: one was a 98-sample dataset with patients who were
manually conﬁrmed pancreatic cancer cases, and the other was a
14,971-sample dataset for patients who did not have ICD-9 diagno-
sis of pancreatic cancer.
As shown in Fig. 3, in this BNI model, all 20 of the risk factor
nodes had only one connection, which was to pancreatic cancer.
The prior probability of each of the two independent variables
(age and smoking/drinking) was obtained by querying the corre-
sponding condition in the EHR. For example, to calculate the prob-
ability P (age P60), a search condition in EHR of ‘‘age at least
60 years old’’ was used. In contrast, for each of the 18 dependent
variables, two search conditions were used. For example, to
calculate the probability P(abdominal pain = true|pancreatic can-
cer = true), we queried the condition ‘‘abdominal pain = true’’
among the patients who had pancreatic cancer. The calculated
prior probabilities for the twenty risk factors are described in
Tables 2 and 3. To calculate the prior probability P(pancreatic
cancer = true|(age P60 AND smoking/drinking = true)), we ﬁrst
queried patients satisfying the two conditions: ‘‘is equal to or older
than 60 years’’ and ‘‘is a smoker and a drinker’’, among whom we
searched for patients who had ‘‘pancreatic cancer’’. Table 4 shows
the prior probabilities for the pancreatic cancer node.
2.6. Graphic user interface development
We developed a graphic user interface, iDiagnosis, for the
weighted BNI model using the Professional Version of MicrosoftTable 4
Calculated prior probabilities of pancreatic cancer to be true under the conditions of
age and substance (smoking or drinking) abuse (data source: EHR for the entire
patient population).
Pancreatic cancer = true AgeP 60 Age < 60
Smoking/drinking = true 0.00002 0.00001
Smoking/drinking = false 0.0008 0.0003Visual Studio 2010. iDiagnosis includes two main functions: the
Bayesian function and the eUtils function. The Bayesian part real-
izes the inferences in a Bayesian Network using a Pearl’s Mes-
sage-Passing algorithm [6,25,26]. The eUtils part is responsible
for generating search terms, searching and fetching PubMed pa-
pers, and accessing MySQL data tables. Fig. 5a and b display the
interface for the Bayesian part and the interface for the eUtils part,
respectively.
2.7. Model evaluation
Our evaluation consisted of two parts: (1) comparing the
weighted BNI model to the conventional BNI model using the data
set that contained the 98 cases and 14,971 controls; and (2) com-
paring the weighted BNI model to two other popular classiﬁcation
models, KNN and SVM, in the open sourceWeka package [22]. Note
that part one used only aggregated de-identiﬁed information for
the 14,971 control set to calculate prior probabilities, as shown
in Table 3, without requiring individual patient information for
each of the 20 risk factors. However, KNN and SVM required more
patient-level information than the BNI models for feature repre-
sentation needed by machine-learning. Therefore, for part two,
we reused the 98 cases but reduced the control group size from
14,971 to 196 since it was impractical to obtain the values of the
20 risk factors for each of the 14,971 controls. The 196-patient con-
trols included 106 randomly selected patients without pancreatic
cancer and 90 with symptoms similar to pancreatic cancer but
without pancreatic cancer. We constructed a feature matrix with
the size being 294 (patients) by 20 (risk factors) and divided the
combined case and control, 294 in total, into two groups with
the ratio between the training and the testing patients being 1–3
so that there were 73 training patients, consisting of 24 cases
and 49 controls, and 221 testing patients, including 74 cases and
147 controls. When implementing SVM, the training data were
centered on zero mean and scaled to a standard deviation of value
1. We selected the linear function (dot product) as the SVM kernel.
To optimize the search for the separating hyper-plane by using
quadratic programming, the interior point method was applied
[27]. The soft margin was used by setting the value of the addi-
tional constraint C as 1.
All four models were applied to classify each patient. We com-
pared performances by measuring sensitivity, speciﬁcity, and accu-
racy. The deﬁnition of accuracy is provided below:
Fig. 5. The interfaces of iDiagnosis for (a) the Bayesian function and (b) the eUtils function.
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true positiveþ false positiveþ true negativeþ false negative :
We drew the ROC curves for the weighted BNI, the conventional
BNI, KNN and SVM, and compared area under curve (AUC), standard
error (SE) and 95% conﬁdence interval (CI) for each to evaluate each
one’s performance.
3. Results
Table 1 shows the resulting normalized weights and variable
rankings. The top three variables associated with pancreatic can-
cer, ranked by importance, were: weight loss, abnormal glucose,
and abnormal CA 19-9. According to the PubMed weights, these
variables weigh about 50 times more than the most weakly associ-
ated variables (GGT and ALT). Table 2 shows the prior probabilities
of P(Vi = true|pancreatic cancer = true) for each of the 20 risk factors
and their frequencies in pancreatic cancer patients. Note thestrength of an association is measured by the weights, or the fre-
quency of the PubMed citation of the association. In contrast to
the PubMed weighting results, the top three most frequent vari-
ables appearing in pancreatic cancer patients EHR were: glucose,
albumin, and nausea. The most frequent variable, glucose, is about
50 times more frequent than the least frequent variable, jaundice.
Table 3 shows the prior probabilities of P(Vi = true|pancreatic can-
cer = false) for patients without pancreatic cancer. The three least
frequent variables in patients without pancreatic cancer were:
GGT, glucose, and bilirubin. Table 5 shows the sensitivity, speciﬁc-
ity, accuracy, and ROC curve of the weighted BNI, the conventional
BNI, KNN and SVM. The accuracy indicated by the AUC value of the
weighted BNI (0.910) is signiﬁcantly higher than that of the con-
ventional BNI (0.806), KNN (0.718) and SVM (0.727) with
P < 0.0001. Fig. 6 shows the ROC curves for the weighted BNI, the
conventional BNI, KNN and SVM. All ROC curves are on the
upper-left side of ROC space, but the ROC curve of the weighted
BNI is higher than that of the conventional BNI, KNN and SVM,
Table 5
Comparative performance of the weighted BNI, the conventional BNI, KNN and SVM: the weighted BNI model is 10% more accurate than the conventional BNI model for
pancreatic cancer prediction.
Sensitivity Speciﬁcity Accuracy ROC
AUC SE 95% CI
Weighted BNI 0.847 0.852 0.850 0.910 0.021 (0.869, 0.951)
Conventional BNI 0.796 0.704 0.735 0.806 0.029 (0.750, 0.863)
KNN 0.650 0.332 0.389 0.718 0.046 (0.654, 0.776)
SVM 0.768 0.396 0.534 0.727 0.043 (0.663, 0.785)
Fig. 6. Comparison of ROC curves of the weighted BNI, the conventional BNI, KNN
and SVM: the weighted BNI model is more accurate than the conventional BNI, KNN
and SVM for pancreatic cancer prediction.
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for pancreatic cancer prediction. Results in Fig. 6 and Table 5 sug-
gest that the weighted BNI is signiﬁcantly more accurate than the
conventional BNI, KNN and SVM for pancreatic cancer prediction
(P < 0.0001).4. Discussion
In this paper, we developed a weighted BNI model for pancre-
atic cancer prediction by combining PubMed knowledge and EHR
data to calculate the ratio between the positive and negative evi-
dence for the associations between each risk factor and the target
disease. The evaluation results indicate that the weighted BNI sig-
niﬁcantly outperformed the conventional BNI and two other classi-
ﬁcation models for pancreatic cancer prediction. This result can be
explained by the following characteristics of the weighted BNI
model. First, the posterior probabilities of the weighted BNI are
determined by two data sources, the ratio between the positive–
negative evidence for the association between the risk factor and
the disease and the prior probability of each risk factor in EHR,
both being important empirical evidence for disease risk predic-
tion. The more frequently a risk factor can be found in EHR, the
higher the posterior probability of the risk factor. The weighted
BNI can tell clinically relevant variables from clinically irrelevant
variables and weigh the relevant variables according to PubMed
evidence. The conventional BNI can recommend risk factors only
by using high posterior probability of statistical signiﬁcance. More-
over, some approaches simply eliminate irrelevant variables; how-
ever, we keep seemingly irrelevant variables in the model but use
PubMed knowledge to avoid abusing their prior probability. Our
design seems to be more realistic and sensitive than a simpliﬁed
model that disregards such variables. To our knowledge, the
weighted BNI is a novel approach to handling clinically irrelevantvariables for disease risk prediction. Our results in Table 5 and
Fig. 6 conﬁrm our hypothesis that the weighted BNI model can
overcome the limitations in the conventional BNI based on pure
probabilities.
The weighted BNI also outperformed KNN and SVM for pancre-
atic cancer prediction. This may be because of two reasons. Firstly,
the BNI model better serves risk prediction than other classiﬁca-
tion models by using a small number of variables. Our model con-
tains only 20 variables. KNN and SVM, on the other hand, usually
excel in a high-dimensional feature space, such as highly dimen-
sional microarray datasets and do not show advantages in low-
dimensional feature space. Secondly, the weighted BNI obtains
information of the association between the variables and pancre-
atic cancer from the topology of Bayesian Network and the weights
from PubMed and EHR, while KNN and SVM do not have such
knowledge to support accurate prediction.
The combination of PubMed and EHR knowledge and informa-
tion for weighing risk factors can be used to generate hypotheses
about the clinical signiﬁcance of an association between a variable
and pancreatic cancer by a combined analysis of its frequency in
patients with pancreatic cancer (Table 2) and in patients without
pancreatic cancer (Table 3). For example, glucose is top ranked in
Table 2, but appears at the bottom in Table 3. This result indicates
a positive association between glucose and pancreatic cancer,
which is consistent with scientiﬁc knowledge in that glucose is
the second most frequently studied variable in pancreatic cancer
research due to the association between diabetes and pancreatic
cancer.
According to Eq (1.1) and (1.2), the weight woi represents the ra-
tio between the number of PubMed abstracts of positive associa-
tion (Pi) and the number of PubMed abstracts of negative
association (Ni) for each risk factor i. If Pi is bigger than Ni, then
the original weight woi is bigger than 1, which means there is more
positive than negative evidence showing variable Vi is associated
with pancreatic cancer; if Pi is smaller than Ni, then the original
weight Fig. 4 is smaller than 1, which means that there is more
negative than positive evidence indicating that variable Vi is asso-
ciated with pancreatic cancer. In Table 1, almost all the original
weights woi are >1, which may imply that most PubMed publica-
tions about risk factors are positive results and negative results
are rare. Because we cannot tell if there is a publication bias toward
only positive association, this warrants further study to guide the
use of PubMed evidence.
We identiﬁed several tasks as future work to continuously im-
prove the weighted BNI model for disease risk prediction. First, a
highly accurate dataset is crucial to realizing the full potential of
the weighted BNI and the software iDiagnosis for pancreatic cancer
risk prediction. In this paper, we reused a dataset of manually re-
viewed 98 cases [21]; however, we faced signiﬁcant challenges
when it came to verifying the completeness and accuracy of the
information for the larger sample population, the 14,971-patient
control group. Each variable entails laborious information extrac-
tion and summarization from PubMed and EHR. The same variable
may be reﬂected in multiple formats in different data sources (e.g.,
ICD-9 codes, various types of notes, and other structured data
sources such as lab results) in EHR. Our unstructured EHR data in
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medical natural language processing software, MedLEE [10,28–31],
but the data accuracy was not close to 100%. Time was an issue in
this study as for the smaller case sample we used manual review to
compensate for the NLP limitations, which was time consuming.
We also lacked a method to reconcile the inconsistencies between
structured and unstructured data sources. Development, valida-
tion, and reuse of sophisticated phenotyping algorithms in the
EHR are much needed to improve the efﬁciency and accuracy of
EHR phenotyping.
Second, although the weighted BNI model improves the accu-
racy for pancreatic cancer prediction over conventional BNI and
the other two popular classiﬁcation methods, it can be improved
in multiple aspects, including the efﬁciency for variable generation
and selection, prior probabilities calculation, and variable weights
calculation. In this study, we selected 20 variables to predict pan-
creatic cancer risks. It is possible that unknown variables related to
pancreatic cancer have not been included in our model. It is be-
yond our current capacity to deﬁne a model with hundreds or
thousands of ﬁne-grained phenotypic features related to pancre-
atic cancer. Therefore, efﬁcient discovery of unknown disease fea-
tures is a challenging research topic that needs more future work.
Moreover, in this study, we used the batch processing mode to
obtain data to calculate prior probabilities from EHR. It would be
more efﬁcient to support prior probability calculation using a
real-time data warehouse to automatically update the parameters
of the model online as the warehouse receives updates. An ad-
vanced analytical framework based on efﬁcient EHR-phenotyping
algorithms can be developed to increase the efﬁciency of dynamic
prior probability calculation for each risk factor in vivo.
Finally, in this weighted BNI network, we weighted nodes only.
As an alternative, the causal edges between nodes can be weighted.
In [32], Zhou et al. developed a causal edge weighted BNI for visual
tracking, and the authors achieved better recognition results thanTable A1
Keywords indicating positive association, negative association, and neutral association bet
Variable Positive Negative
Chronic
pancreatitis
Risk, link, associated, association, inﬂuence,
relation, relationship, coexist, following, relevance,
surround, complicate, complicating, predispose,
predisposing
Differentiat
compare, d
differentiat
distinguish
difference,
Diabetes Relevance, relationship, relation, associated,
association, risk, clue, interaction, early symptom,
cause, link, following, presence, prevalence,
complicated, effect, growth, inﬂuence, follow-up,
revelatory, co-existing
Comparison
Alcohol Risk, effect, association, factor, relationship
Smoking Risk, associated, association, evidence, relation,
interaction
CA 19-9 Marker, covariate, biomarker, predicting,
detection, estimation, diagnosing, predict,
indicator, predictor, management, appraisal, tumor
marker, association, monitoring, diagnosis, predict,
diagnostic, evaluating, prognosis, index, correlate,
determination, associated, measurement,
inﬂuence, determining, evaluation, related,
correlative
CEA Marker, tumor marker, diagnosis, diagnostic, role,
associated, suspected, establishment,
characterization, relation, detection
Insulin Promote, biomarker, risk, effect, determinant,
augment, correlation
Reversal
Age Impact, evidence, importance, diagnosis
Glucose Promote, association, predictor, risk, cause,
diagnosis, effect, clue, increased, augment,
relationship, mortality, induce, detection,
Reducewhen using a conventional BNI. One of our future works is to inves-
tigate the efﬁcacy of weighing causal edges for improving the pre-
dictive accuracy of BNI.5. Conclusion
We developed a weighted BNI using both PubMed knowledge
and EHR data to weigh network nodes for pancreatic cancer predic-
tion. We demonstrated that the weighted BNI model showed
remarkable improvement in prediction accuracy over the conven-
tional BNI for pancreatic cancer prediction (P < 0.0001). We con-
clude that an integration of a statistical summary of PubMed
knowledge and real-world evidence collected from EHR data can
improve weighting of the variables in a BNI model and improve
its disease predictive accuracy. More studies are warranted to gen-
eralize the ﬁndings here to allow modeling of other diseases based
on the integration of PubMed and EHR knowledge.
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Neutral
ion, differentiation, differential,
istinguish, comparison,
e, discrimination, distinction,
, difference, differentiating,
discriminate, comparison, versus
Sequential
, resectability
Perillyl alcohol, alcohol dehydrogenase
Prognosis, prognostic, follow-up, survival,
resectable, therapy, recurrence
Follow-up, therapy, recurrence
Insulin receptor, insulin promoter, insulin-
like growth factor, insulin resistance
Survival
Glucose-deprived, glucose transporter,
postoperative, surgery, therapy,
pancreatectomy, resectability, prognostic,
(continued on next page)
Table A1 (continued)
Variable Positive Negative Neutral
associated, effect prognosis, graft, glucose intolerance,
glucose intolerance, mortality
Obesity Role, explain, potentiate, risk, relation, evidence Lack of association Survival, gastrectomy, prognostic, prognosis
Abdominal
pain
role, cause, caused, consistent with, symptom, due
to, present, suspected, suspicion, diagnosis,
diagnosed, experienced, investigation, detect,
resulting from, result from, component
Rare Survival, therapy, managing, manage,
management, unresectable
Jaundice Role, explain, potentiate, risk, relation, evidence,
effect, caused, due to, detection, with jaundice,
inﬂuence, complicated by, complicating, due to
Role, explain, potentiate, risk, relation,
evidence, effect, caused, due to, detection,
with jaundice, inﬂuence, complicated by,
complicating, due to
Nonresectable, surgical, management,
operative, survival
With or without obstructive jaundice
Weight loss Correlation, symptom, documented, suffering, hint,
signiﬁcant, feature, contributes to, effect,
contribution, presenting, assessment, associated
Not associated with
Bilirubin Suspicious, associated, marker, increased Prognostic, survival, association
Asthenia Symptom, diagnose, detection Phase, grade, advanced pancreatic cancer,
adverse event, toxicities, dosing, dose, stage,
toxicity
CT Diagnosis, impact, detecting, diagnostic,
signiﬁcance, assessment, evaluation, detection,
possibility, value, evaluation, conﬁrmed
Recurrence, advanced pancreatic cancer,
unresectable, resectability, therapy, liver
metastasis, preoperative, management,
resectable, staging, evaluation, tumor
MRI Diagnosis, correlation, diagnostic Therapy, mimic, advanced pancreatic
cancer, staging, tumor, resectability,
therapeutic
General Not related, no relationship, unrelated,
irrelevant, unassociated, unconnected, no
association, irrelative, independent, beside
the point, dissimilar
Equal to, same to
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